NCT06927297 2026-03-17Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid TumorsWest China HospitalPhase 1 Recruiting12 enrolled
NCT06649708 2025-01-14HX044,FIH Study in Patients with Advanced Solid Tumor MalignanciesHangzhou Hanx Biopharmaceuticals, Ltd.Phase 1/2 Recruiting100 enrolled